RRoche Read More Roche’s Oncology Pipeline Shows Promise in Treating Aggressive Brain Metastases2026-03-29 Roche’s trastuzumab, capecitabine, and tucatinib combo more than doubled median survival to 10 months in HER2+ breast cancer…
ZZürich Read More Zurich Insurance Charts Aggressive Growth Path Amid Record Profits2026-03-14 Zurich posts record 2025 profits and raises $5B for Beazley buy, but its stock faces near-term pressure as…